Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hetero Europe is the European subsidiary of Hetero, a leading global pharmaceutical company based in India. The company specializes in the development, manufacturing, and marketing of high-quality generic medicines, with a significant focus on complex generics and biosimilars. Hetero is globally recognized as one of the largest producers of anti-retroviral (ARV) drugs for HIV/AIDS treatment, supplying a substantial portion of the global demand. In the European market, the company provides a diverse portfolio of therapeutic solutions across oncology, cardiovascular, and central nervous system disorders. Leveraging its parent company's extensive vertical integration, Hetero Europe also offers contract manufacturing and development services (CDMO) to international partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hetero Europe.